HK1114024A1 - 純化藍綠藻的提取物及其使用的方法 - Google Patents

純化藍綠藻的提取物及其使用的方法

Info

Publication number
HK1114024A1
HK1114024A1 HK08109673.7A HK08109673A HK1114024A1 HK 1114024 A1 HK1114024 A1 HK 1114024A1 HK 08109673 A HK08109673 A HK 08109673A HK 1114024 A1 HK1114024 A1 HK 1114024A1
Authority
HK
Hong Kong
Prior art keywords
blue
green algae
purified extracts
extracts
purified
Prior art date
Application number
HK08109673.7A
Other languages
English (en)
Inventor
Gitte S Jensen
Christian Drapeau
Original Assignee
Desert Lake Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Desert Lake Tech filed Critical Desert Lake Tech
Publication of HK1114024A1 publication Critical patent/HK1114024A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/748Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
HK08109673.7A 2005-06-24 2008-09-01 純化藍綠藻的提取物及其使用的方法 HK1114024A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69380805P 2005-06-24 2005-06-24
US70088205P 2005-07-19 2005-07-19
PCT/US2006/024769 WO2007002570A1 (en) 2005-06-24 2006-06-23 Purified component of blue-green algae and method of use

Publications (1)

Publication Number Publication Date
HK1114024A1 true HK1114024A1 (zh) 2008-10-24

Family

ID=37188001

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08109673.7A HK1114024A1 (zh) 2005-06-24 2008-09-01 純化藍綠藻的提取物及其使用的方法

Country Status (13)

Country Link
US (3) US7651690B2 (zh)
EP (1) EP1895973B1 (zh)
JP (1) JP5006877B2 (zh)
KR (1) KR101489728B1 (zh)
AU (1) AU2006261852B2 (zh)
BR (1) BRPI0612672B8 (zh)
CA (1) CA2612694C (zh)
ES (1) ES2546332T3 (zh)
HK (1) HK1114024A1 (zh)
IL (1) IL188192A (zh)
NZ (1) NZ565346A (zh)
RU (1) RU2417093C2 (zh)
WO (1) WO2007002570A1 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6814961B1 (en) 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
US8795679B2 (en) * 2006-05-05 2014-08-05 Blaa Lonid Hf Pharmaceutical and cosmetic use of extracts from algae obtainable from saline hot water sources
US9522167B2 (en) * 2006-06-27 2016-12-20 Nutratec, s.r.l. Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders
KR20090048399A (ko) * 2006-06-27 2009-05-13 뉴트라테크 에스.알.엘. 아파니조메논 플로스 아쿠애 추출물 및 이를 포함하는 영양, 미용 및 약제학적 조성물
US20080124318A1 (en) * 2006-11-28 2008-05-29 Jerold Lisson Algae supplement and treatment method
KR20100062140A (ko) * 2008-12-01 2010-06-10 부경대학교 산학협력단 푸코이단을 함유하는 골 형성 촉진 및 활성용 약학 조성물
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US9370537B2 (en) 2009-04-03 2016-06-21 Cerule, Llc Compositions and methods for reducing inflammation
IT1394412B1 (it) * 2009-06-05 2012-06-15 Eni Spa Procedimento per l'essiccazione di biomassa algale
WO2011141906A2 (en) * 2010-05-11 2011-11-17 Benzion Geshuri Pharmaceutical composition comprising an algae adapted to increase the efficacy of an enzymatic inhibitor
AU2011276479B2 (en) * 2010-06-28 2015-06-25 Stemtech International, Inc. Methods and compositions for enhancing stem cell mobilization
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
US8685845B2 (en) 2010-08-20 2014-04-01 International Business Machines Corporation Epitaxial growth of silicon doped with carbon and phosphorus using hydrogen carrier gas
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
MX2014005652A (es) 2011-11-18 2014-09-01 Stemtech International Inc Uso de foti para potenciar la movilizacion y proliferacion de celulas madre.
CA2874483A1 (en) * 2012-07-11 2014-01-16 Stemtech International, Inc. Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells
TWI618796B (zh) 2012-12-06 2018-03-21 幹細胞生物科技股份有限公司 Lgr5+體幹細胞
EP2746770A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
US20150141901A1 (en) * 2013-11-08 2015-05-21 Alan S. Lichtbroun Low-level laser irradiation of stimulated human stem cells
CA2932237C (en) * 2013-12-03 2022-12-13 Gerolymatos International S.A. Ionic aqueous compositions comprising sulfated polysaccharides
CN107312063A (zh) * 2017-06-22 2017-11-03 乐清瑞耀食品技术有限公司 钝顶螺旋藻活性蛋白的制备方法
FR3087338B1 (fr) * 2018-10-22 2020-10-09 Amadeite Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5663911A (en) 1979-10-29 1981-05-30 Dainippon Ink & Chem Inc Cosmetic containing hard-soluble phycocyanin
US6309639B1 (en) * 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
DK1681299T3 (da) * 2000-03-27 2010-02-01 Genetics Inst Llc Fremgangsmåde til rensning af højt anioniske proteiner
PL203814B1 (pl) * 2000-07-10 2009-11-30 Univ Mississippi Preparat immunostymulujacy wyodrębniony z mikroalg, kompozycja farmaceutyczna i suplement diety zawierające ten preparat, zastosowanie preparatu immunostymulującego oraz sposób otrzymywania tego preparatu z jadalnych mikroalg
JP2002069443A (ja) * 2000-08-30 2002-03-08 Microalgae Corporation 抗酸化剤及び該抗酸化剤を含有する化粧料
EP1421174B1 (en) * 2000-10-18 2009-12-23 The Brigham And Women's Hospital, Inc. Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
US6814961B1 (en) * 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
FR2850277B1 (fr) * 2003-01-24 2005-04-08 Lanatech Composition comprenant un extrait d'aphanizomenon flos-aquae, son utilisation et sa preparation

Also Published As

Publication number Publication date
US7651690B2 (en) 2010-01-26
RU2008100847A (ru) 2009-07-27
RU2417093C2 (ru) 2011-04-27
ES2546332T3 (es) 2015-09-22
CA2612694A1 (en) 2007-01-04
BRPI0612672B1 (pt) 2018-12-11
IL188192A (en) 2014-04-30
US7947284B2 (en) 2011-05-24
EP1895973B1 (en) 2015-08-19
KR20080030047A (ko) 2008-04-03
EP1895973A1 (en) 2008-03-12
BRPI0612672B8 (pt) 2021-05-25
IL188192A0 (en) 2011-08-01
WO2007002570A1 (en) 2007-01-04
NZ565346A (en) 2010-05-28
US20100209461A1 (en) 2010-08-19
AU2006261852B2 (en) 2012-07-19
KR101489728B1 (ko) 2015-02-04
AU2006261852A1 (en) 2007-01-04
JP2008546808A (ja) 2008-12-25
US20100092507A1 (en) 2010-04-15
CA2612694C (en) 2015-10-27
US20070003647A1 (en) 2007-01-04
BRPI0612672A2 (pt) 2010-11-30
JP5006877B2 (ja) 2012-08-22

Similar Documents

Publication Publication Date Title
HK1114024A1 (zh) 純化藍綠藻的提取物及其使用的方法
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
IL176958A0 (en) Compounds and methods of use
EP1913112A4 (en) SUPPORTING AGENT AND METHODS OF USE
EP1843768A4 (en) SUBSTITUTED MORPHINANES AND METHODS OF USE
EP1744744A4 (en) BIOACTIVE COMPOUNDS AND METHODS OF USE THEREOF
IL187303A0 (en) Methods of prepering 3 - cyano - quinolines and intermediates made thereby
ZA200608180B (en) Solid product dissolver and method of use thereof
GB0325192D0 (en) Method of use
AP2006003595A0 (en) Methods for enhancing stress tolerance of plants and methods
ZA200801100B (en) Substituted triazoles as modulators of ppar and methods of their preparation
ZA200607582B (en) Anti-parasitic compounds and methods of their use
HK1135099A1 (en) Aza-indolyl compounds and methods of use
IL186342A0 (en) Spirocyclic heterocycic derivaives and methods of their use
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
HK1071163A1 (en) Anti-fouling composition and method of production thereof
ZA200806226B (en) 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrim-idines as jak 2 modulators and methods of use
EP1812451A4 (en) COMPOUNDS AND METHODS OF USE THEREOF
EP1747494A4 (en) GLASSES AND ASSOCIATED MANUFACTURING METHOD
EP1735281A4 (en) SYNTHESIS OF INDENOISOQUINOLINIUMS AND TECHNIQUES OF USE
ZA200709024B (en) Method of well treatment and construction
EP1946007A4 (en) ANDROSTERONE DERIVATIVES AND METHODS OF USE
GB0520930D0 (en) Composition and method of use
EP1978999A4 (en) ISOLATED MCPIP PROTEIN AND METHODS OF USE
IL186277A0 (en) Dnt-maleate and methods of preparation thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220623